TY - JOUR
T1 - Zinc supplementation in infants born small for gestational age reduces mortality
T2 - A prospective, randomized, controlled trial
AU - Sazawal, Sunil
AU - Black, Robert E.
AU - Menon, Venugopal P.
AU - Dinghra, Pratibha
AU - Caulfield, Laura E.
AU - Dhingra, Usha
AU - Bagati, Adeep
PY - 2001
Y1 - 2001
N2 - Background. Low birth weight infants have been noted to have low zinc concentrations in cord blood, and zinc deficiency in childhood is associated with reduced immunocompetence and increased infectious disease morbidity. This study investigates whether zinc supplementation of infants born full term and small for gestational age affects mortality. Methods. A randomized, double-blind, controlled trial with 2-by-2 factorial design enrolled 1154 full-term small for gestational age infants to receive in syrup 1 of the following: riboflavin; riboflavin and zinc (5 mg as sulfate); riboflavin, calcium, phosphorus, folate, and iron; or riboflavin, zinc, calcium, phosphorus, folate, and iron. A fixed dosage of 5 Ml per child was given daily from 30 to 284 days of age. Household visits were made 6 days per week to provide the syrup and conduct surveillance for illness and death. When a child's death was reported, parental reports and medical records were used to ascertain the cause. The effects of zinc and of the combination of iron, folate, calcium, and phosphorus were analyzed by intent to treat. The mortality analysis was performed using a survival analytic approach that models time until death as the dependent variable; all models had 2 terms as independent variables: 1 for the zinc effect and 1 for the vitamin and mineral (calcium and phosphorus, folate and iron) effect. Results. Zinc supplementation was associated with significantly lower mortality, with a rate ratio of 0.32 (95% confidence interval: 0.12-0.89). Calcium, phosphorus, folate, and iron supplementation was not associated with a mortality reduction, although a statistically nonsignificant trend toward reduction was observed with a rate ratio of 0.88 (95% confidence interval: 0.36-2.15). Conclusion. Zinc supplementation in small for gestational age infants can result in a substantial reduction in infectious disease mortality.
AB - Background. Low birth weight infants have been noted to have low zinc concentrations in cord blood, and zinc deficiency in childhood is associated with reduced immunocompetence and increased infectious disease morbidity. This study investigates whether zinc supplementation of infants born full term and small for gestational age affects mortality. Methods. A randomized, double-blind, controlled trial with 2-by-2 factorial design enrolled 1154 full-term small for gestational age infants to receive in syrup 1 of the following: riboflavin; riboflavin and zinc (5 mg as sulfate); riboflavin, calcium, phosphorus, folate, and iron; or riboflavin, zinc, calcium, phosphorus, folate, and iron. A fixed dosage of 5 Ml per child was given daily from 30 to 284 days of age. Household visits were made 6 days per week to provide the syrup and conduct surveillance for illness and death. When a child's death was reported, parental reports and medical records were used to ascertain the cause. The effects of zinc and of the combination of iron, folate, calcium, and phosphorus were analyzed by intent to treat. The mortality analysis was performed using a survival analytic approach that models time until death as the dependent variable; all models had 2 terms as independent variables: 1 for the zinc effect and 1 for the vitamin and mineral (calcium and phosphorus, folate and iron) effect. Results. Zinc supplementation was associated with significantly lower mortality, with a rate ratio of 0.32 (95% confidence interval: 0.12-0.89). Calcium, phosphorus, folate, and iron supplementation was not associated with a mortality reduction, although a statistically nonsignificant trend toward reduction was observed with a rate ratio of 0.88 (95% confidence interval: 0.36-2.15). Conclusion. Zinc supplementation in small for gestational age infants can result in a substantial reduction in infectious disease mortality.
KW - Micronutrients
KW - Mortality
KW - Randomized trial
KW - Zinc
UR - http://www.scopus.com/inward/record.url?scp=0035195607&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035195607&partnerID=8YFLogxK
U2 - 10.1542/peds.108.6.1280
DO - 10.1542/peds.108.6.1280
M3 - Article
C2 - 11731649
AN - SCOPUS:0035195607
SN - 0031-4005
VL - 108
SP - 1280
EP - 1286
JO - Pediatrics
JF - Pediatrics
IS - 6
ER -